{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:40:12Z","timestamp":1780612812419,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00192-018-3772-6","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T02:38:34Z","timestamp":1538447914000},"page":"1195-1201","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Perioperative adverse events in women undergoing concurrent urogynecologic and gynecologic oncology surgeries for suspected malignancy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-748X","authenticated-orcid":false,"given":"Emily R. W.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Woodburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"AlHilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"11","key":"3772_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.300.11.1311","volume":"300","author":"I Nygaard","year":"2008","unstructured":"Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in us women. JAMA. 2008;300(11):1311\u20136.","journal-title":"JAMA"},{"issue":"5","key":"3772_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/AOG.0b013e3182a7ef3c","volume":"122","author":"SG Thomas","year":"2013","unstructured":"Thomas SG, Sato HR, Glantz JC, Doyle PJ, Buchsbaum GM. Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol. 2013;122(5):976\u201380.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"3772_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00192-016-2962-3","volume":"27","author":"CE Bretschneider","year":"2016","unstructured":"Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ. Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study. Int Urogynecol J. 2016;27(9):1409\u201314.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"3772_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ygyno.2014.04.002","volume":"133","author":"KM Doll","year":"2014","unstructured":"Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133(3):546\u201351.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3772_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2217\/fon.10.96","volume":"6","author":"DM Chase","year":"2010","unstructured":"Chase DM, Watanabe T, Monk BJ. Assessment and significance of quality of life in women with gynecologic cancer. Future Oncol. 2010;6(8):1279\u201387.","journal-title":"Future Oncol"},{"issue":"Suppl 1","key":"3772_CR6","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1016\/S0020-7292(06)60040-4","volume":"95","author":"RT Penson","year":"2006","unstructured":"Penson RT, Wenzel LB, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. Figo 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95(Suppl 1):S247\u201357.","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"3772_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00192-015-2907-2","volume":"27","author":"SA Sullivan","year":"2016","unstructured":"Sullivan SA, Davidson ER, Bretschneider CE, Liberty AL, Geller EJ. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2016;27(5):811\u20136.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"3772_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00192-010-1137-x","volume":"21","author":"G Sutkin","year":"2010","unstructured":"Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and\/or incontinence. Int Urogynecol J. 2010;21(8):955\u201361.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"3772_CR9","doi-asserted-by":"publisher","first-page":"603 e1","DOI":"10.1016\/j.ajog.2014.11.034","volume":"212","author":"CA Unger","year":"2015","unstructured":"Unger CA, Walters MD, Ridgeway B, Jelovsek JE, Barber MD, Paraiso MF. Incidence of adverse events after uterosacral colpopexy for uterovaginal and posthysterectomy vault prolapse. Am J Obstet Gynecol. 2015;212(5):603 e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"32","key":"3772_CR10","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1200\/JCO.2009.22.3248","volume":"27","author":"JL Walker","year":"2009","unstructured":"Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study lap2. J Clin Oncol. 2009;27(32):5331\u20136.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3772_CR11","doi-asserted-by":"publisher","first-page":"547 e1","DOI":"10.1016\/j.ajog.2014.07.054","volume":"211","author":"CA Unger","year":"2014","unstructured":"Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547 e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"3772_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"key":"3772_CR13","unstructured":"JMP\u00ae, Version 14. SAS Institute Inc., Cary, NC, 1989-2007."},{"key":"3772_CR14","doi-asserted-by":"publisher","unstructured":"Bochenska K, Mueller M, Geynisman-Tan J, Leader-Cramer A, Dave B, Lewicky-Gaupp C, et al. Concomitant repair of pelvic floor disorders in women undergoing surgery for gynecologic malignancies. Female Pelvic Med Reconstr Surg. 2018. \n                    https:\/\/doi.org\/10.1097\/SPV.0000000000000579\n                    \n                  .","DOI":"10.1097\/SPV.0000000000000579"},{"issue":"2","key":"3772_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/AOG.0000000000002731","volume":"132","author":"CE Bretschneider","year":"2018","unstructured":"Bretschneider CE, Sheyn D, Mahajan ST, Ferrando CA. Adverse events after concurrent procedures for gynecologic malignancies and pelvic floor disorders. Obstet Gynecol. 2018;132(2):274\u201380.","journal-title":"Obstet Gynecol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-018-3772-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-018-3772-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T19:08:13Z","timestamp":1569956893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-018-3772-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3772"],"URL":"https:\/\/doi.org\/10.1007\/s00192-018-3772-6","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no direct conflicts of interest for this work. Dr. Ferrando is an author for and receives royalties from UpToDate\u00ae and has unrestricted research grants from Coloplast and Caldera.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}